FDA approves Pharmion's Vidaza
The FDA granted marketing approval to PHRM for its Vidaza azacitidine to treat myelodysplastic syndromes (MDS). The company plans to
Gathering data...
The FDA granted marketing approval to PHRM for its Vidaza azacitidine to treat myelodysplastic syndromes (MDS). The company plans to